Match Document Document Title
US20130122297 MOLECULAR GAUGE BLOCKS FOR BUILDING ON THE NANOSCALE  
Disclosed herein is a way to produce a series of discrete sized slender, rigid oligoparaxylene molecules ranging from 1-5 nm in length. Molecules, based on 1-7, 9-11 paraxylene rings, have been...
US20130041016 Compositions and Methods for Preventing and Treating Cancer via Modulating UBE1L, ISG215 and/or UBP43  
Compositions and methods of using compositions that induce UBE1L or a ubiquitin-like protein ISG15, or inhibit a deconjugase UBP43 to degrade oncogenic proteins and enhance apoptosis of cancer...
US20110269991 PURE CARBOXYLIC ACID FILTRATION  
The present invention relates to a process for production of pure terephthalic acid comprising: a) removing a mother liquor from a terephthalic acid through a filter with a gas, wherein the gas...
US20130078198 NOVEL USE  
This invention relates to the use of sodium dodecylbenzene sulphonate (SDDBS) for helping to prevent or remove surface deposited stains from natural teeth and dental prostheses and oral care...
US20140051772 CLEANING AGENT COMPOSITION  
The problem of the present invention is provision of a cleansing composition providing good amount and good quality of lather. Using a particular alkenoic acid or a salt thereof, the...
US20140239231 Carbon Dioxide Conversion To Fuels And Chemicals  
An environmentally beneficial process for the production of fuels and chemicals employs carbon dioxide from a natural source or from an artificial chemical source that would otherwise be...
US20120020881 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes  
This invention relates to novel compounds suitable for labeling by positron emitting isotopes, such as 18F, 11C, 13N and 15O, through appropriate labeling reagents, such as 18F reagents and...
US20120302788 METHODS FOR PRODUCTION OF ARGININE AT LOW PRESSURE  
A method of producing arginine bicarbonate is provided including reacting an arginine slurry with a source of carbon dioxide gas under elevated temperature and low pressure to form a solution of...
US20130303761 COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR PROTEIN MALFUNCTION  
The present invention relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The...
US20130122141 FLAVOR CONTAINING L-GLUTAMIC ACID AND METHOD THEREOF  
Disclosed herein is a method for producing a flavoring containing L-glutamic acid derived from natural foods by adjusting the content of ammonia remaining in a final fermentation broth after...
US20110105608 MODULATORS OF NUCLEAR RECEPTOR CO-REGULATORY PROTEIN BINDING  
Disclosed are novel compounds and compositions for inhibition of androgen and estrogen receptor signaling, methods for inhibiting androgen signaling, methods for inhibiting estrogen signaling,...
US20140316158 METHOD OF OBTAINING ACETATE FROM LIGNOCELLULOSE SPECIFICATION IDENTIFICATION  
A method of obtaining an aqueous solution of an alkali acetate from lignocellulose, wherein lignocellulose is treated with a first aqueous extraction solution having a pH value in the range of 12...
US20150073131 METHOD FOR PRODUCING BIOBASED CHEMICALS FROM PLANT LIGNIN  
The present invention is directed generally to a method of production of value-added, biobased chemicals from lignin sources, including waste lignin. A method of producing biobased aromatic...
US20140378735 METHOD OF DETOXIFYING ASBESTOS CONTAINED IN WASTE SLATE AND DETOXIFIED ASBESTOS OBTAINED THROUGH THE SAME  
Disclosed is a method of detoxifying asbestos of waste slate. The method includes concentrating the asbestos by introducing hydrochloric acid aqueous solution into waste slate powder to dissolve...
US20110059924 Chemoprevention of Colorectal Cancer by Mesalamine/Sulfasalazine  
A method for preventing or treating colorectal cancer in a patient possessing human tropomyocin isoform TC22 is presented. Also presented is a method for evaluating TC22 expression reduction...
US20110201707 ISOCYANATE TRIMERISATION CATALYST SYSTEM, A PRECURSOR FORMULATION, A PROCESS FOR TRIMERISING ISOCYANATES, RIGID POLYISOCYANURATE/POLYURETHANE FOAMS MADE THEREFROM, AND A PROCESS FOR MAKING SUCH FOAMS  
The instant invention provides an isocyanate trimerisation catalyst system, a precursor formulation, a process for trimerising isocyanates, rigid foams made therefrom, and a process for making...
US20150246876 HIGH-PURITY SODIUM P-STYRENESULFONATE WITH EXCELLENT HUE, METHOD FOR PRODUCING THE SAME, POLY (SODIUM P-STYRENESULFONATE) WITH EXCELLENT HUE USING THE SAME, AND DISPERSANT AND SYNTHETIC STARCH FOR CLOTHING FINISHING USING THE POLY ( SODIUM P-STYRENESULFONATE)  
Provided are high purity sodium p-styrenesulfonate with an excellent hue which is useful as a reactive emulsifier or dispersant for producing a polymer emulsion, or synthetic starch for clothing...
US20140206901 RECOMBINANT MICROORGANISMS AND METHODS OF USE THEREOF  
The invention relates to methods for the production of chemical compounds, particularly but not exclusively ethanol, by microbial fermentation. Also described are genetically modified...
US20140117280 OXYGEN ABSORBER  
An oxygen absorber is provided that contains at least one of compounds each having a particular structure, and the oxygen absorber exhibits an oxygen absorbing capability without a metal...
US20150247281 REDUCED MEDICAL WET PACKS, POST STEAM STERILIZATION  
The present disclosure describes a surfactant treatment for a polyolefinic nonwoven fabric used to wrap items to be sterilized. The surfactant treatment consists essentially of carbon, hydrogen...
US20110252507 TRANSGENIC PLANTS USED AS A BIOREACTOR SYSTEM  
The present invention relates generally to the use of plants as bioreactors for the production of molecules having useful properties such as inter alia polymers, metabolites, proteins,...
US20110165098 METHODS TO PREVENT CYTOTOXICITY USING N-ACETYL-CYSTEINE  
Compositions and methods to inhibit adverse physiological effects caused by resin-based and resin-containing materials are disclosed. More specifically, the use of N-acetyl-cysteine (NAC) to...
US20120157392 Epilepsy treatment employing ketogenic compounds which arrest apoptosis  
Method of treating a patient suffering from apoptosis of tissue by administering to the patient a therapeutically effective amount of one or more ketogenic compounds such that a physiological...
US20150057325 COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST  
The present invention relates to novel uses of compounds that protect the endothelium, particularly prostacyclin and variants and derivatives thereof in the treatment or prevention of acute...
US20130261177 COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST  
The present invention relates to novel uses of compounds that protect the endothelium, particularly prostacyclin and variants and derivatives thereof in the treatment or prevention of acute...
US20120195984 DIAGNOSIS AND TREATMENT OF THE PRODROMAL SCHIZOPHRENIC STATE  
Described herein are compounds (including medical foods, pharmaceutical compositions, methods of compounding them), methods and systems for the diagnosis and/or treatment of prodromal...
US20140242606 PROBE FOR iFRET AND USE THEREOF  
The present invention relates to a probe for iFRET and use thereof. Specifically, the present invention relates to a novel probe for iFRET, a method for preparing the probe for iFRET, a method for...
US20150073176 LINEAR ALKYLBENZENES FROM NATURAL OILS AND METHODS OF PRODUCING  
A linear alkylbenzene product and a linear alkylbenzene sulfonate product from a natural oil are provided. The linear alkylbenzene product comprises alkylbenzenes having the formula C6H5CnH2n+1...
US20110176998 IMAGING AND THERAPY OF VIRUS-ASSOCIATED TUMORS  
The present invention features compositions and methods for detecting, selecting a treatment method for, monitoring, and treating a neoplasia associated with a viral infection.
US20120264902 Methods, Systems and Compositions for Increased Microorganism Tolerance to and Production of 3-Hydroxypropionic Acid (3-HP)  
The present invention relates to methods, systems and compositions, including genetically modified microorganisms, adapted to exhibit increased tolerance to 3-hydroxypropionic acid (3-HP),...
US20120003156 METHODS FOR TREATING NEOPLASIA BY INHIBITING LACTATE DEHYDROGENASE AND/OR NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE  
The invention provides compositions for the diagnosis or treatment of neoplasias, including lymphomas, leukemias, brain cancers (e. glioblastomas, medulloblastomas), breast cancer, colon cancer,...
US20140256817 AMPHIPATHIC AND OTHER DOUBLE-SIDED ALPHA-HELIX MIMETICS BASED ON A 1,2-DIPHENYLACETYLENE SCAFFOLD  
Small-molecule scaffolds based on 1,2-diphenylacetylene that accurately replicate the spatial and angular projections of several side chains on both faces of an α-helix, specifically the i and i+7...
US20130143967 Organosulfur compounds for the prevention and treatment of neurodegenerative diseases  
S-allylmercapto-N-acetylcysteine and related compounds are disclosed which can be administered in order to provide protection from the formation of aldehyde-protein adducts, protein carbonylation,...
US20110269689 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS  
High penetration compositions (HPC) of a parent compound, which are capable of crossing biological barriers with high penetration efficiency. The HPCs are capable of being converted to parent...
US20110189094 BIOLOGICAL METHOD FOR IN VIVO TRACKING OF MOLECULES AFFECTING CELLULAR MIGRATION  
Cellular migration is a normal part of the normal development of the human being and, in certain pathologies, its alteration damages physiological performance, so that it is necessary to learn...
US20120088782 LPA RECEPTOR ANTAGONIST  
A compound of the general formula (I): (wherein the symbols are as defined in the description), or a non-toxic salt thereof. This compound engages in LPA receptor bonding and antagonism and hence...
US20120142958 CHEMICAL RECYCLING OF PLA BY HYDROLYSIS  
A process for recycling a polymer blend necessarily containing PLA, comprising grinding, compacting, dissolving in a solvent of PLA, removing the undissolved contamining polymers, alcoholysis...
US20120178966 METHODS FOR PRODUCTION OF L-METHIONINE AND RELATED PRODUCTS  
A method comprising: (a) enzymatically processing an O-acetylhomoserine (OAHS) fermentation liquor to produce L-methionine and an acetate source; (b) separating at least a portion of said...
US20110064712 Dietary Supplement Compositions and Methods of Making and Using the Same  
Dietary supplement compositions are disclosed. Methods of making and using dietary supplement compositions are also disclosed.
US20150250752 COMPOSITION CONTAINING LYSINE AS A NUTRITIONAL SUPPLEMENT OR TREATMENT IN THE CASE OF HERPES  
The invention relates to a composition comprising, related to a daily dose of the composition, as its active ingredients L-lysine ranging from ≧750 mg to −9 g, suitable as a nutritional supplement...
US20150073170 KINETIC RESOLUTION  
Whilst methodologies for the Kinetic Resolution of alcohols are well established, no analogous direct methods exist for the highly selective, direct catalytic Kinetic Resolution of thiols (i.e.,...
US20120277437 KINETIC RESOLUTION  
Whilst methodologies for the Kinetic Resolution of alcohols are well established, no analogous direct methods exist for the highly selective, direct catalytic Kinetic Resolution of thiols (i.e.,...
US20120220502 COMPOSITIONS COMPRISING ALKYLALKOXYSULFONATES FOR THE PRODUCTION OF HIGH TEMPERATURE STABLE FOAMS  
The present invention is directed to the use of alkylalkoxysulfonates for the production of foams, which are stable at high temperatures, e.g. up to about 250° C. Furthermore, the invention...
US20110319493 HISTONE DEACETYLASES, AND USES RELATED THERETO  
The present invention concerns the discovery that proteins encoded by a family of genes, termed here HDx-related genes, which are involved in the control of chromatin structure and, thus in...
US20110313045 HISTONE DEACETYLASES, AND USES RELATED THERETO  
The present invention concerns the discovery that proteins encoded by a family of genes, termed here HDx-related genes, which are involved in the control of chromatin structure and, thus in...
US20110218154 HISTONE DEACETYLASES, AND USES RELATED THERETO  
The present invention concerns the discovery that proteins encoded by a family of genes, termed here HDx-related genes, which are involved in the control of chromatin structure and, thus in...
US20110251216 COMPOSITIONS AND METHODS FOR INHIBITING EZH2  
The present invention relates to therapeutic targets for cancer. In particular, the present invention relates to small molecules and nucleic acids that target EZH2 expression in cancer (e.g.,...
US20130061752 Tetratopic Phenyl Compounds, Related Metal-Organic Framework Materials and Post-Assembly Elaboration  
Disclosed are tetratopic carboxylic acid phenyl for use in metal-organic framework compounds. These compounds are useful in catalysis, gas storage, sensing, biological imaging, drug delivery and...
US20110280815 COMPOSITION FOR INHIBITING MELANIN PRODUCTION AND APPLICATION THEREOF  
The present invention provides a composition for inhibiting melanin production to promote skin whitening, which is characterized by containing compounds represented by formula (I): wherein R1, R2...
US20150018316 Compounds, Methods, and Treatments for Abnormal Signaling Pathways for Prenatal and Postnatal Development  
The present invention relates to prevention of congenital deformations. The invention further relates to cancer inhibition and prevention. The invention further relates to methods and compositions...